Related references
Note: Only part of the references are listed.Visceral adiposity index is associated with significant fibrosis in patients with non-alcoholic fatty liver disease
S. Petta et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2012)
Systematic review: the diagnosis and staging of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis
J. K. Dowman et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)
The efficacy of entecavir therapy in chronic hepatitis B patients with suboptimal response to adevofir
E. Sheen et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)
Validation of the non-alcoholic fatty liver disease activity score
M. Hjelkrem et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)
Systematic review: association of polycystic ovary syndrome with metabolic syndrome and non-alcoholic fatty liver disease
A. Baranova et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)
Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults
G. Vernon et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)
Changes in the Prevalence of the Most Common Causes of Chronic Liver Diseases in the United States From 1988 to 2008
Zobair M. Younossi et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2011)
High prevalence of colorectal neoplasm in patients with non-alcoholic steatohepatitis
Vincent Wai-Sun Wong et al.
GUT (2011)
The Natural History of Nonalcoholic Fatty Liver Disease With Advanced Fibrosis or Cirrhosis: An International Collaborative Study
Neeraj Bhala et al.
HEPATOLOGY (2011)
Healthy range for serum ALT and the clinical significance of unhealthy normal ALT levels in the Korean population
Hyun Seok Kang et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2011)
Non-alcoholic fatty liver disease's prevalence and impact on alanine aminotransferase associated with metabolic syndrome in the Chinese
Xu-hong Hou et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2011)
Subjects with sonographical hepatic steatosis should be excluded from studies to establish upper reference levels of serum transaminases
Henry Voelzke et al.
LIVER INTERNATIONAL (2011)
A new composite model including metabolic syndrome, alanine aminotransferase and cytokeratin-18 for the diagnosis of non-alcoholic steatohepatitis in morbidly obese patients
R. Anty et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2010)
Nomograms for Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B Virus Infection
Hwai-I Yang et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Synergistic association between alcohol intake and body mass index with serum alanine and aspartate aminotransferase levels in older adults: the Rancho Bernardo Study
R. Loomba et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2009)
Incidence of hepatocellular carcinoma in hepatitis C carriers with normal alanine aminotransferase levels
Takashi Kumada et al.
JOURNAL OF HEPATOLOGY (2009)
The clinical significance of persistently normal ALT in chronic hepatitis B infection
Michelle Lai et al.
JOURNAL OF HEPATOLOGY (2007)
Prevalence and etiology of elevated serum alanine aminotransferase level in an adult population in Taiwan
Chien-Hua Chen et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2007)
Fibrosis progression in initially mild chronic hepatitis C
S Boccato et al.
JOURNAL OF VIRAL HEPATITIS (2006)
Re-evaluation of serum alanine aminotransferase upper normal limit and its modulating factors in a large-scale population study
R Kariv et al.
LIVER INTERNATIONAL (2006)
Prognostic determinants for chronic hepatitis B in Asians: therapeutic implications
MF Yuen et al.
GUT (2005)
The natural history of nonalcoholic fatty liver disease: A population-based cohort study
LA Adams et al.
GASTROENTEROLOGY (2005)
Normal serum aminotransferase concentration and risk of mortality from liver diseases: prospective cohort study
HC Kim et al.
BMJ-BRITISH MEDICAL JOURNAL (2004)
Updated definitions of healthy ranges for serum alanine aminotransferase levels
D Prati et al.
ANNALS OF INTERNAL MEDICINE (2002)
Primary care: Evaluation of abnormal liver-enzyme results in asymptomatic patients.
DS Pratt et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Share Paper
